Related Experiment Video
Updated: Feb 7, 2026
10:29
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
2.4K
Taking regulatory T-cell therapy one step further.
Antoine Sicard1,2,3,4, Dominic A Boardman1,2, Megan K Levings1,2
1British Columbia Children's Hospital Research Institute.
Current Opinion in Organ Transplantation
|August 1, 2018
Summary
Innovations in adoptive cell therapy enhance regulatory T cell (Treg) treatments for autoimmune and alloimmune diseases. Genetic modification and gene editing improve Treg specificity, stability, and function for better therapeutic outcomes.
Area of Science:
- Immunology
- Cell Therapy
- Gene Editing
Background:
- Adoptive cell therapy using CD4FOXP3 regulatory T cells (Treg) shows promise for treating autoimmune and alloimmune conditions.
- Enhancing Treg therapy efficacy involves modifying antigen specificity, stability, and function.
- Recent innovations offer improved control over these Treg parameters.
Purpose of the Study:
- To review recent advancements in Treg therapy.
- To explore strategies for enhancing Treg specificity, stability, and function.
- To discuss the potential of novel Treg modification techniques.
Main Methods:
- Generating antigen-specific Tregs via genetic modification (TCR, CAR).
- Utilizing CRISPR/Cas9 technology for Treg modification.
- Modulating Treg differentiation and homing properties through gene editing and ex-vivo stimulation.
Main Results:
- Novel strategies enable fine-tuning of Treg antigen-specificity and affinity in vivo.
- CRISPR/Cas9 enhances Treg safety, stability, and longevity.
- Gene editing and modified ex-vivo conditions improve Treg differentiation and homing.
Conclusions:
- A growing number of strategies can increase the therapeutic potential of Treg therapy.
- Increased complexity of advanced Treg approaches may limit accessibility.
- Third-party, off-the-shelf Treg products offer a potential solution for wider accessibility.
Related Concept Videos
02:02Cis-regulatory Sequences
11.9K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.9K
02:02Cis-regulatory Sequences
4.2K
4.2K
02:24Regulation of Expression Occurs at Multiple Steps
26.5K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
26.5K
01:28Global Regulatory Systems
692
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
692
00:59Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
03:08Rate-Determining Steps
37.3K
Relating Reaction Mechanisms
In a multistep reaction mechanism, one of the elementary steps progresses significantly slower than the others. This slowest step is called the rate-limiting step (or rate-determining step). A reaction cannot proceed faster than its slowest step, and hence, the rate-determining step limits the overall reaction rate.
The concept of rate-determining step can be understood from the analogy of a 4-lane freeway with a short-stretch of traffic-bottleneck caused due to...
In a multistep reaction mechanism, one of the elementary steps progresses significantly slower than the others. This slowest step is called the rate-limiting step (or rate-determining step). A reaction cannot proceed faster than its slowest step, and hence, the rate-determining step limits the overall reaction rate.
The concept of rate-determining step can be understood from the analogy of a 4-lane freeway with a short-stretch of traffic-bottleneck caused due to...
37.3K